Literature DB >> 3082212

Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma.

L M Weiss, J G Strickler, R F Dorfman, S J Horning, R A Warnke, J Sklar.   

Abstract

Ten cases of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) and AILD-like lymphoma were studied by immunophenotypic and immunogenotypic analysis. All specimens were found to have a predominance of T cells by immunophenotypic analysis. DNA hybridization analyses showed three of five specimens of AILD and five of six specimens of AILD-like lymphoma to contain clonal rearrangements of the beta T-cell receptor gene. No rearrangements of the heavy or light chain immunoglobulin genes were seen in any case. A single case showed a progression of AILD with a germ-line pattern of beta T-cell receptor DNA to AILD-like lymphoma with detectable clonal rearrangements for beta T-cell receptor DNA. These results suggest that many, but not all, cases diagnosed histologically as AILD or AILD-like lymphoma contain a clonal proliferation of T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082212      PMCID: PMC1888223     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes.

Authors:  J C Alwine; D J Kemp; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Amount of viral DNA in the genome of cells transformed by adenovirus type 2.

Authors:  U Pettersson; J Sambrook
Journal:  J Mol Biol       Date:  1973-01       Impact factor: 5.469

5.  Immunoblastic sarcoma arising in child with immunoblastic lymphadenopathy.

Authors:  C B Howarth; C C Bird
Journal:  Lancet       Date:  1976-10-02       Impact factor: 79.321

6.  Malignant lymphoma arising in angioimmunoblastic lymphadenopathy.

Authors:  B N Nathwani; H Rappaport; E M Moran; G A Pangalis; H Kim
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

7.  Letter: Chromosome abnormalities in angioimmunoblastic lymphadenopathy.

Authors:  D K Hossfeld; K Höffken; C G Schmidt; H Diedrichs
Journal:  Lancet       Date:  1976-01-24       Impact factor: 79.321

8.  Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

9.  Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasmacytoid features.

Authors:  R I Fisher; E S Jaffe; R C Braylan; J C Andersen; H K Tan
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

10.  Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy.

Authors:  L M Weiss; E Hu; G S Wood; C Moulds; M L Cleary; R Warnke; J Sklar
Journal:  N Engl J Med       Date:  1985-08-29       Impact factor: 91.245

View more
  21 in total

1.  [Application of digital pathology tools. An unusual case of non-Hodgkin lymphoma].

Authors:  A-S K Meyer; F E Dallenbach; G Lienert; P Möller; J K Lennerz
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 2.  [Diagnostic spectrum of reactive lymph node changes].

Authors:  S Hartmann; S Kriener; M L Hansmann
Journal:  Pathologe       Date:  2008-07       Impact factor: 1.011

3.  Peripheral neuropathy with distal nerve infiltration revealing a diffuse pleiomorphic malignant lymphoma.

Authors:  M Zuber; R Gherardi; M Imbert; P Gaulard; M Kuentz; J Poirier
Journal:  J Neurol       Date:  1987-10       Impact factor: 4.849

Review 4.  Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification.

Authors:  T Suchi; K Lennert; L Y Tu; M Kikuchi; E Sato; A G Stansfeld; A C Feller
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

5.  Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy.

Authors:  J L Smith; E Hodges; C T Quin; K P McCarthy; D H Wright
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma.

Authors:  Yi Zhou; Marc K Rosenblum; Ahmet Dogan; Achim A Jungbluth; April Chiu
Journal:  J Hematop       Date:  2015-03-18       Impact factor: 0.196

7.  In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study.

Authors:  Klaus Willenbrock; Christoph Renné; Philippe Gaulard; Martin-Leo Hansmann
Journal:  Virchows Arch       Date:  2004-10-05       Impact factor: 4.064

8.  Phenotyping of proliferating lymphocytes in angioimmunoblastic lymphadenopathy and related lesions by the double immunoenzymatic staining technique.

Authors:  R Namikawa; T Suchi; R Ueda; G Itoh; K Koike; K Ota; T Takahashi
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

9.  Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues.

Authors:  J Lorenzen; G Li; M Zhao-Höhn; C Wintzer; R Fischer; M L Hansmann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Genetic changes in atypical hyperplasia and lymphoma with angioimmunoblastic lymphadenopathy and dysproteinaemia in the same patients.

Authors:  K Ohshima; M Kikuchi; M Hashimoto; M Kozuru; N Uike; S Kobari; Y Masuda; Y Sumiyoshi; S Yoneda; M Takeshita
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.